We are live on ! Find out more
GL

Graypoint LLC Portfolio holdings

AUM $1.78B
1-Year Est. Return 16.72%
This Fund
S&P 500
This Quarter Est. Return
-3.04%
1 Year Est. Return
+16.72%
3 Year Est. Return
+72.83%
5 Year Est. Return
+113.84%
10 Year Est. Return
AUM
$1.6B
AUM Growth
-$47.8M
Cap. Flow
+$22.5M
Cap. Flow %
1.4%
Top 10 Hldgs %
32.76%
Holding
533
New
19
Increased
231
Reduced
218
Closed
27

Sector Composition

Rank Sector Weight
1 Technology 13.52%
2 Financials 7.86%
3 Healthcare 3.66%
4 Consumer Discretionary 2.96%
5 Communication Services 2.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTIP icon
151
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$1.48M 0.09%
29,626
+125
+0.4% +$6.14K
CORP icon
152
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.59B
$1.46M 0.09%
15,053
-315
-2% -$30.2K
ICE icon
153
Intercontinental Exchange
ICE
$79B
$1.45M 0.09%
8,409
+1,591
+23% +$261K
NYF icon
154
iShares New York Muni Bond ETF
NYF
$1.37B
$1.45M 0.09%
27,500
VRTX icon
155
Vertex Pharmaceuticals
VRTX
$123B
$1.41M 0.09%
2,914
+12
+0.4% +$5.59K
BSV icon
156
Vanguard Short-Term Bond ETF
BSV
$44.7B
$1.4M 0.09%
17,937
+2,167
+14% +$168K
TT icon
157
Trane Technologies
TT
$104B
$1.39M 0.09%
4,128
-91
-2% -$32.9K
BLK icon
158
Blackrock
BLK
$166B
$1.37M 0.09%
1,452
+34
+2% +$33.3K
SRLN icon
159
State Street Blackstone Senior Loan ETF
SRLN
$5.3B
$1.37M 0.09%
33,364
+3,691
+12% +$154K
GILD icon
160
Gilead Sciences
GILD
$167B
$1.36M 0.08%
12,156
+965
+9% +$99.6K
BBHY icon
161
JPMorgan BetaBuilders USD High Yield Corporate Bond ETF
BBHY
$614M
$1.35M 0.08%
29,284
+2,506
+9% +$116K
TMO icon
162
Thermo Fisher Scientific
TMO
$198B
$1.35M 0.08%
2,705
+250
+10% +$135K
VRP icon
163
Invesco Variable Rate Preferred ETF
VRP
$3B
$1.32M 0.08%
54,475
+139
+0.3% +$3.38K
PGR icon
164
Progressive
PGR
$121B
$1.31M 0.08%
4,630
-50
-1% -$13.1K
SYK icon
165
Stryker
SYK
$123B
$1.3M 0.08%
3,485
+51
+1% +$19.4K
WFC.PRL icon
166
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.72B
$1.29M 0.08%
1,074
REGN icon
167
Regeneron Pharmaceuticals
REGN
$70.9B
$1.28M 0.08%
2,015
-93
-4% -$64K
WFC icon
168
Wells Fargo
WFC
$265B
$1.27M 0.08%
17,704
-494
-3% -$37.1K
GSLC icon
169
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.4B
$1.27M 0.08%
11,502
+379
+3% +$43.8K
QCOM icon
170
Qualcomm
QCOM
$181B
$1.25M 0.08%
8,169
+462
+6% +$75.3K
AMD icon
171
Advanced Micro Devices
AMD
$808B
$1.22M 0.08%
11,885
-564
-5% -$62.7K
AMP icon
172
Ameriprise Financial
AMP
$47.5B
$1.22M 0.08%
2,512
-272
-10% -$143K
GRND icon
173
Grindr
GRND
$2.71B
$1.22M 0.08%
67,899
QQQ icon
174
Invesco QQQ Trust
QQQ
$466B
$1.21M 0.08%
2,583
+1,192
+86% +$606K
BMY icon
175
Bristol-Myers Squibb
BMY
$124B
$1.18M 0.07%
19,421
+3,423
+21% +$200K

Similar funds

Graypoint LLC's Q1 2025 Portfolio in Review

As of Q1 2025, Graypoint LLC held 533 positions worth $1.6B, down 2.9% from $1.65B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Graypoint LLC's Q1 2025 filing shows 19 new, 231 increased, 218 reduced and 27 closed positions. Its largest new stake was iShares International Dividend Active ETF: 166,695 shares worth $4.32M. The largest sale was NVIDIA, an estimated $3.02M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

  • Graypoint LLC's largest Q1 2025 buy was iShares International Dividend Active ETF: 166,695 shares worth $4.32M.
  • Graypoint LLC added most to Vanguard S&P 500 Growth ETF in Q1 2025, an estimated $10.9M increase.
  • Graypoint LLC's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $3.02M.
  • Graypoint LLC fully exited Clover Health Investments in Q1 2025, selling an estimated $632K.
  • Graypoint LLC's ten largest holdings make up 33% of its $1.6B portfolio in Q1 2025.
  • Graypoint LLC opened 19 new positions and closed 27 in Q1 2025.
  • Graypoint LLC's portfolio value fell 2.9% quarter-over-quarter to $1.6B.

Based on Graypoint LLC's 13F filing for Q1 2025, filed 2 May 2025.